Biotech Asset Value 
Unlock your value potential

Imugene
Glaceum
Mthera pharma
Image
TSCI
Peaccel
AGV Discovery
MenoGenix
logo amcure

Biotechs That Trust Us

Asset Value 
Discover the Value of Your Asset

Understanding the value of your asset is essential when preparing for company valuations, investment rounds, M&A transactions, or licensing deals.

The Liberi Group Asset Value Calculator empowers you with data-driven insights that help you make smarter, more confident strategic decisions and strengthen your negotiation position.

Using the calculator is simple and efficient. Just provide a few key assumptions, and we’ll generate a value estimate based on a robust, industry-standard risk-adjusted net present value (rNPV) method. This approach takes into account both the potential future returns and the risks involved, giving you a realistic, well-rounded view of your asset’s potential.

After completing the calculation, you will receive your current rNPV estimate directly by email. From there, you have the option to download a full Asset Value Report, which includes detailed value inflection points, or connect with our Value Service experts for a more comprehensive, personalized consultation.

Instructions

Valuation

Asset Valuation Calculator

Home Page Logo

Regulatory Costs Assumptions

In which regions would you like to obtain approval? Select Yes or No.

Development Stage Assumptions

Please fill the costs (in millions) and duration (in years) for each relevant development stage; if a stage is already completed, fill ‘0’ for both costs and years.
$
$
$
$
$
$
$

Patient Assumptions

Please fill in the Patient assumptions.

INDICATION 1

%
%
%
%
%
%

INDICATION 2

%
%
%
%
%
%

Drug Price Assumptions

Please fill in the expected drug price per region in dollars.
$
$
$

Commercial Stage Assumptions

Please fill in the commercial stage assumptions belows.

Company Description

Both checkboxes must be checked to proceed.
×

By accessing or utilizing this online Asset Value Calculator (hereinafter ‘Calculator’) and any associated information provided through the website of Liberi Life Science Consultancy B.V. and trading under the name Liberi Group (hereinafter both referred to as the overarching term Liberi Group), the user expressly acknowledges and agrees to the following terms and conditions:

  • Any document arising from the use of this Calculator is provided for informational purposes only and shall not be interpreted or relied upon as advice, guidance, or a recommendation for making business, financial, or investment decisions.
  • Liberi Group, including its affiliates and subsidiaries, disclaims all liability in respect of decisions or actions taken – in the broadest possible sense – based on or in reliance to this Calculator or any information derived therefrom.
  • The consenting user remains solely and fully responsible for the accuracy, completeness, and lawfulness of all data or information entered into the Calculator and acknowledges that such input has not been verified or validated by Liberi Group.
  • Liberi Group shall not be liable for any form of loss or damage, whether direct, indirect, incidental, special, punitive, exemplary, or consequential in nature. This includes, without limitation, damages arising from business interruption, loss of revenue, loss of data or programs, loss of anticipated profits, or any other economic or financial loss, regardless of the cause of action, even where Liberi Group has been advised of, or could reasonably have foreseen, the possibility of such damages.
  • No rights, entitlements, or claims may be derived from the content of any document arising from the use of this Calculator. All intellectual property rights in and to the content remain the exclusive property of Liberi Group.

Asset Valuation Report - Payment

Our Valuation Approach

Scientific analysis

Understanding your science,  therapeutic area, research phase, clinical data, IP strength and company roadmap

Market Analysis

Deep dive into market trends, competitive landscape, and growth projections for your specific assets. 

Growth Potential

Regulatory pathway analysis and approval probability by phase, Future value trajectory modeling with risk-adjusted NPV calculations

Evaluation

Evaluation of financial output, report generation and client feedback 

Biotech Industry Expertise

At Liberi Group, we understand the unique challenges and opportunities in the biotech sector. Our valuation methodology is specifically tailored to account for:

  • Regulatory approval probabilities by indication and phase
  • Time-to-market considerations and development timelines
  • Reimbursement landscape and pricing potential
  • Strategic partnership and acquisition trends
  • Platform technology scalability and pipeline potential
"Working with the Liberi Group has been a pleasure. They are professional, collaborative, and understand the partner’s objectives and work diligently to help achieve the goals.”
Monil Shah - CBO - Imugene

Ready for our Value Service?

Our team of industry experts provides detailed valuations that go beyond the calculator, incorporating qualitative factors and strategic considerations.

Connect